ProCE Banner Activity

CE / CME

Precision Skin Cancer Diagnosis: Gene Expression Profiling for Melanoma and cSCC

Video

This activity, Precision Skin Cancer Diagnosis: Gene Expression Profiling for Melanoma and cSCC, will review emerging trends in diagnosis and risk stratification for patients with common skin cancers. This will include practical discussion of how to improve diagnosis of melanoma and new strategies to improve risk stratification for melanoma and cSCC.

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit™

Nurse Practitioners: 1.00 AANP contact hour

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Released: September 30, 2022

Expiration: September 30, 2023

No longer available for credit.

Share

Faculty

Sylvana Brickley

Sylvana Brickley, DNP, FNP-BC, DCNP

Lahey Dermatology
Burlington, Massachusetts

Aaron S. Farberg

Aaron S. Farberg, MD, FAAD

Medical Director
Derm Texas
Dermatology Research Institute
Assistant Professor
Baylor Scott & White Health System
Dallas, Texas

Cynthia Griffith

Cynthia Griffith, MPAS, PA-C

Physician Assistant University of Texas Southwestern Medical Center
Department of Dermatology
Editor in Chief Journal of Dermatology Physician Assistants
Dallas, Texas

Sherrif Ibrahim

Sherrif Ibrahim, MD, PhD

Associate Professor of Dermatology
University of Rochester Medical Center
Rochester, New York

Provided by

This activity is provided by PCME and Rockpointe

ProCE Banner
ProCE Banner

Supporters

This activity is supported by an educational grant from Castle Biosciences, Inc.

Castle Biosciences, Inc.

Target Audience

The intended audience for this educational initiative is physicians, physician assistants, and nurse practitioners, clinicians who are often involved in the diagnosis and initial assessment of skin cancer.

Learning Objectives

At the conclusion of an activity, participants should be able to:

  • Evaluate current and emerging clinical trial data for gene expression profiling in melanoma diagnosis

  • Identify high‐risk patients with melanoma based on the latest staging systems and gene expression profiling

  • Discuss the utility of emerging gene expression profiling assays for risk stratification of cSCC

Disclosure

Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other relevant professional organizations, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of an accredited continuing education program provided by the Potomac Center for Medical Education are required to disclose to PCME all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by PCME in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by PCME to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by PCME.

Faculty, Authors, and Content Developers
The faculty, authors and content developers reported the following relevant financial relationships with ineligible companies:

Primary Author

Sylvana Brickley, DNP, FNP-BC, DCNP

Lahey Dermatology
Burlington, Massachusetts

Sylvana Brickley, DNP, FNP-BC, DCNP: has no relevant financial relationships.

Aaron S. Farberg, MD, FAAD

Medical Director
Derm Texas
Dermatology Research Institute
Assistant Professor
Baylor Scott & White Health System
Dallas, Texas

Aaron S. Farberg, MD, FAAD: Consulting Fee: Amgen, Castle Biosciences, Galderma, Incyte, Novartis, Pfizer, Sun Pharmaceuticals, Ortho-Dermatologics

Cynthia Griffith, MPAS, PA-C

Physician Assistant University of Texas Southwestern Medical Center
Department of Dermatology
Editor in Chief Journal of Dermatology Physician Assistants
Dallas, Texas

Cynthia Griffith, MPAS, PA-C: has no relevant financial relationships 

Sherrif Ibrahim, MD, PhD

Associate Professor of Dermatology
University of Rochester Medical Center
Rochester, New York

Sherrif F. Ibrahim, MD, PhD: Consulting Fee: Castle, Galderma, Regeneron; Contracted Research: Biofrontera, Castle, Galderma, Regeneron, Replimune; Honoraria: Castle, Genentech, Regeneron; Speakers' Bureau: Castle, Genentech, Regeneron

FDA DISCLOSURE
The contents of some CME activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

Instructions for Credit

There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME activity in its entirety, and then complete the post-test, with a score of 70% or better, and evaluation. The estimated time for completion of this activity is 1 hour. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test. Participant is allowed to take the post-test multiple times.

Accreditation

PHYSICIAN ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN CREDIT DESIGNATION STATEMENT
The Potomac Center for Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For questions regarding CME credit or the evaluation, please email contact@potomacme.org.

AMERICAN ASSOCIATION OF NURSE PRACTIONERS (AANP) CREDIT DESIGNATION STATEMENT
This activity is approved for 1.0 contact hour(s) of continuing education (which includes 0 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 22095768. This activity was planned in accordance with AANP Accreditation Standards and Policies.

AMERICAN ASSOCIATION OF PHYSICIAN ASSISSTANTS (AAPA) CREDIT DESIGNATION STATEMENT
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 9/30/2022 to 9/30/2023 . PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-208016.